Sign in

CIK 0001785530

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Werewolf Therapeutics, Inc.

Sign in to watch
Ticker
HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
823523180
Phone
+1 617-952-0555
Business address
303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-05-24 Atkins Michael B. Director Grant or award · Stock Option (right to buy) +6,723 6,723
2024-05-24 Chatterjee Meeta Director Grant or award · Stock Option (right to buy) +17,500 17,500
2024-05-24 Sherman Michael A. Director Grant or award · Stock Option (right to buy) +17,500 17,500
2024-05-24 EVNIN LUKE Director Grant or award · Stock Option (right to buy) +17,500 17,500
2024-05-24 Lazarus Alon Director Grant or award · Stock Option (right to buy) +17,500 17,500
2024-01-04 Atkins Michael B. Director Grant or award · Stock Option (right to buy) +35,000 35,000
2024-01-02 Trost Timothy W. Chief Financial Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2024-01-02 Lubman Ellen Chief Business Officer Grant or award · Stock Option (right to buy) +131,900 131,900
2024-01-02 Isaacs Randi Chief Medical Officer Grant or award · Stock Option (right to buy) +200,000 200,000
2024-01-02 Karunatilake Chulani Chief Technology Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2024-01-02 Seidel-Dugan Cynthia Chief Scientific Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2024-01-02 HICKLIN DANIEL J Grant or award · Stock Option (right to buy) +435,000 435,000
2023-06-21 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option (Right to Buy) −13,200 13,200
2023-06-21 Morrison Briggs Director Grant or award · Stock Option (right to buy) +13,200 13,200
2023-06-21 EVNIN LUKE Director Grant or award · Stock Option (right to buy) +13,200 13,200
2023-06-21 Lazarus Alon Director Grant or award · Stock Option (right to buy) +13,200 13,200
2023-06-21 DiRocco Derek Director Grant or award · Stock Option (right to buy) +13,200 13,200
2023-06-21 Chatterjee Meeta Director Grant or award · Stock Option (right to buy) +13,200 13,200
2023-06-21 Sherman Michael A. Director Grant or award · Stock Option (right to buy) +13,200 13,200
2023-01-06 RA CAPITAL MANAGEMENT, L.P. Director Purchase +1,853,000 $2.21 $4.1M 5,701,056

Page 11 of 17 · 335 trades